These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 16343642

  • 21. Examining the diagnostic utility of EEG power measures in children with attention deficit/hyperactivity disorder.
    Magee CA, Clarke AR, Barry RJ, McCarthy R, Selikowitz M.
    Clin Neurophysiol; 2005 May; 116(5):1033-40. PubMed ID: 15826843
    [Abstract] [Full Text] [Related]

  • 22. ERP indices of working memory updating in AD/HD: differential aspects of development, subtype, and medication.
    Keage HA, Clark CR, Hermens DF, Williams LM, Kohn MR, Clarke S, Lamb C, Crewther D, Gordon E.
    J Clin Neurophysiol; 2008 Feb; 25(1):32-41. PubMed ID: 18303558
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. EEG abnormalities in adolescent males with AD/HD.
    Hobbs MJ, Clarke AR, Barry RJ, McCarthy R, Selikowitz M.
    Clin Neurophysiol; 2007 Feb; 118(2):363-71. PubMed ID: 17166762
    [Abstract] [Full Text] [Related]

  • 27. Cognitive and electroencephalographic disturbances in children with attention-deficit/hyperactivity disorder and sleep problems: new insights.
    Sawyer AC, Clark CR, Keage HA, Moores KA, Clarke S, Kohn MR, Gordon E.
    Psychiatry Res; 2009 Dec 30; 170(2-3):183-91. PubMed ID: 19854519
    [Abstract] [Full Text] [Related]

  • 28. Children with attention-deficit/hyperactivity disorder and autistic features: EEG evidence for comorbid disorders.
    Clarke AR, Barry RJ, Irving AM, McCarthy R, Selikowitz M.
    Psychiatry Res; 2011 Jan 30; 185(1-2):225-31. PubMed ID: 20580838
    [Abstract] [Full Text] [Related]

  • 29. Age and gender effects in EEG coherence: II. Boys with attention deficit/hyperactivity disorder.
    Barry RJ, Clarke AR, McCarthy R, Selikowitz M, Johnstone SJ, Hsu CI, Bond D, Wallace MJ, Magee CA.
    Clin Neurophysiol; 2005 Apr 30; 116(4):977-84. PubMed ID: 15792908
    [Abstract] [Full Text] [Related]

  • 30. Dexamphetamine normalises electrophysiological activity in attention deficit-hyperactivity disorder during the Stroop task.
    Horrobin SL, McNair NA, Kirk IJ, Waldie KE.
    Neurocase; 2007 Oct 30; 13(5):301-10. PubMed ID: 18781428
    [Abstract] [Full Text] [Related]

  • 31. Symptoms of attention-deficit/hyperactivity disorder following traumatic brain injury in children.
    Levin H, Hanten G, Max J, Li X, Swank P, Ewing-Cobbs L, Dennis M, Menefee DS, Schachar R.
    J Dev Behav Pediatr; 2007 Apr 30; 28(2):108-18. PubMed ID: 17435461
    [Abstract] [Full Text] [Related]

  • 32. Prescribed stimulant use by Western Australians with Attention Deficit Hyperactivity Disorder (ADHD): does amount dispensed exceed the expected authorised use?
    Calver J, Sanfilippo F, Preen D, Bulsara M.
    Aust N Z J Public Health; 2007 Dec 30; 31(6):533-9. PubMed ID: 18081573
    [Abstract] [Full Text] [Related]

  • 33. Behavioural and ERP indices of response inhibition during a Stop-signal task in children with two subtypes of Attention-Deficit Hyperactivity Disorder.
    Johnstone SJ, Barry RJ, Clarke AR.
    Int J Psychophysiol; 2007 Oct 30; 66(1):37-47. PubMed ID: 17604142
    [Abstract] [Full Text] [Related]

  • 34. EEG coherence adjusted for inter-electrode distance in children with attention-deficit/hyperactivity disorder.
    Barry RJ, Clarke AR, McCarthy R, Selikowitz M, Johnstone SJ.
    Int J Psychophysiol; 2005 Oct 30; 58(1):12-20. PubMed ID: 15922471
    [Abstract] [Full Text] [Related]

  • 35. Managing ADHD in general practice. N of 1 trials can help!
    Duggan CM, Mitchell G, Nikles CJ, Glasziou PP, Del Mar CB, Clavarino A.
    Aust Fam Physician; 2000 Dec 30; 29(12):1205-9. PubMed ID: 11140235
    [Abstract] [Full Text] [Related]

  • 36. Varying required effort during interference control in children with AD/HD: task performance and ERPs.
    Johnstone SJ, Watt AJ, Dimoska A.
    Int J Psychophysiol; 2010 Jun 30; 76(3):174-85. PubMed ID: 20362016
    [Abstract] [Full Text] [Related]

  • 37. EEG differences between good and poor responders to methylphenidate and dexamphetamine in children with attention-deficit/hyperactivity disorder.
    Clarke AR, Barry RJ, McCarthy R, Selikowitz M.
    Clin Neurophysiol; 2002 Feb 30; 113(2):194-205. PubMed ID: 11856625
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Visual function and ocular features in children and adolescents with attention deficit hyperactivity disorder, with and without treatment with stimulants.
    Grönlund MA, Aring E, Landgren M, Hellström A.
    Eye (Lond); 2007 Apr 30; 21(4):494-502. PubMed ID: 16518370
    [Abstract] [Full Text] [Related]

  • 40. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ, Merkel RL, Moore M, Thorndike F, Muller C, Kovatchev B.
    Pediatrics; 2006 Sep 30; 118(3):e704-10. PubMed ID: 16950962
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.